Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))

Alzheimer's Disease Clinical Trial

Official title:

Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01993628
• Other study ID #: 5565
• Status: Recruiting
• Phase: N/A
• First received: October 31, 2013
• Last updated: November 18, 2013
• Start date: October 2013
• Est. completion date: November 2016

Study information

• Verified date: November 2013
• Source: University Hospital, Strasbourg, France
• Contact: Xavier DE PETIGNY, Docteur
• Phone: 3 88 11 56 24
• Email: xavier.depetigny[@]chru-strasbourg.fr
• Is FDA regulated: No
• Health authority: France: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

Alzheimer's disease (AD) and Lewy body's dementia (LBD) are two frequent neurodegenerative pathologies. They differ in their expression, their evolution but share same features which make their diagnosis uneasy.

Constructional apraxia has been described in both disease.The underlying mechanisms have been less studied and could be different in AD and LBD.

The definition of the constructional apraxia is purely descriptive and few models are inconclusive.

It is admitted that drawing tasks involve visuo-perceptive and visuo-spatial abilities, executive functions and working memory as well as purely "constructive" skills.

Regarding to different studies, visuo-perceptive abilities are more severely impaired in LBD than in AD and are considered as an early onset sign of the disease.

Executive functions deficits are documented in AD and LDB and could contribute to the drawing impairment.

It is possible to compensate the planning disorders in giving patient the best strategy to use.

If drawing impairment persists, they should result of others mechanisms like visuo-perception, visuo-spatial or constructive deficits.

The investigators suggest that giving the best planning strategy will help more AD patients who are supposed to fail in raison of an executive impairment, than the LDB group who is supposed to present visuo-perceptive deficits. An MRI will be proposed to study the cerebral areas involved in constructional apraxia.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 80
• Est. completion date: November 2016
• Est. primary completion date: November 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 45 Years and older

Eligibility

Inclusion Criteria:

• Alzheimer's disease or Lewy bodies dementia

• = 45 years

• the cognitive impairment is mild to moderate

• French speaker

• a caregiver is present

• An informed consent is signed by the patient and the p.i.

Exclusion Criteria:

• MRI contraindication

• Other neurological disease (FTD, brain tumor, vascular disease…)

• Psychiatric disease (Schizophrenia, major depression, psychotic disorders, melancholia…)

• Patient who doesn't want to be informed in case of the discovery of an abnormality

• View or audition deficits, or motor disability which can interfere with the cognitive testing

• Patient participating to an exclusive protocol or in the period of exclusion

• Pregnant woman

• Person under an administrative or legal measure of liberty privation

• Person under a legal measure of protection or under administrative supervision

• Person unable to give his consent

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Alzheimer Disease
• Alzheimer's Disease
• Dementia
• Lewy Body Disease
• Lewy Body's Dementia

Intervention

Other:
• Rey figure test

• MRI

Locations

Country	Name	City	State
France	Hôpitaux Universitaires de Strasbourg	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Score obtained at the Rey figure test with a planning strategy help by LBD patients compared to the score obtained by AD patients.		At inclusion	No